APG Asset Management US’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-30,996
Closed -$2.97M – 75
2025
Q3
$2.97M Buy
30,996
+564
+2% +$58.4K 0.02% 89
2025
Q2
$3.19M Hold
30,432
– – 0.02% 84
2025
Q1
$3.08M Hold
30,432
– – 0.02% 85
2024
Q4
$2.72M Sell
30,432
-3,711
-11% -$327K 0.02% 85
2024
Q3
$2.87M Sell
34,143
-394,648
-92% -$31.1M 0.02% 83
2024
Q2
$32.8M Buy
428,791
+9,513
+2% +$696K 0.19% 69
2024
Q1
$28.6M Buy
419,278
+132,308
+46% +$8.51M 0.17% 75
2023
Q4
$16.6M Buy
+286,970
New +$15.3M 0.1% 77

Other funds holding BSX

APG Asset Management US's BSX Position: Q4 2025 in Review

APG Asset Management US sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 30,996 shares — an estimated $2.97M sold.

APG Asset Management US first reported a position in BSX in Q4 2023 and held it in 8 quarters. The position peaked at $32.8M in Q2 2024. 1,795 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

  • APG Asset Management US reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
  • APG Asset Management US sold 30,996 Boston Scientific shares in Q4 2025, an estimated $2.97M.
  • APG Asset Management US first reported a position in Boston Scientific in Q4 2023 and held it in 8 quarters.
  • APG Asset Management US's Boston Scientific position peaked at $32.8M in Q2 2024.
  • 1,795 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on APG Asset Management US's 13F filing for Q4 2025, filed 12 Feb 2026.